+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07679282

Comparing PAP Therapy, Dental Devices, and Atomoxetine-Oxybutynin Medications for Adults with Obstructive Sleep Apnea

Led by Sairam Parthasarathy · Updated on 2026-10-19

2400

Participants Needed

4

Research Sites

113 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing three treatments for adults with obstructive sleep apnea OSA to find which works best and is easiest to use regularly. This study evaluates traditional positive airway pressure PAP therapy, a dental device, and a combination of two FDA-approved medications atomoxetine and oxybutynin that are used for other conditions. Participants must have a recent OSA diagnosis and symptoms such as snoring or daytime sleepiness. Participants will be randomly assigned to one of three groups using a PAP machine, wearing a dental device during sleep, or taking the medication combination. These treatments are studied over one year to assess their effectiveness and ease of use. The study includes two in-person visits and four phone check-ins during this time. During the study, participants will complete surveys, report side effects, and discuss treatment adherence. Researchers will measure quality of life, sleep apnea severity, sleep impairment, blood pressure changes, treatment adherence, and side effects at 12 months. The total participation lasts one year with regular monitoring to understand how each treatment impacts health and daily life.

CONDITIONS

Brief Title

A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults

Research Team

H

Heidi Erickson, BSN, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here